You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
ScandiBio Therapeutics Enters Phase III With Mitochondrial-Focused Alzheimer's Treatment
Text:
Tommie Anderberg | [email protected]
With an unusually low profile, ScandiBio Therapeutics has prepared its biggest step yet – a Phase III study of over 600 Alzheimer's patients. The study, which focuses on restoring the brain's energy production, marks...